Can a light-based treatment called photobiomodulation help to treat degenerative brain diseases?
Determined collaboration and groundbreaking technology have led to exciting advances in efforts to solve the challenges of brain diseases, researchers from the MassGeneral Institute for Neurodegenerative Diseases(MIND) told patients, families and friends recently. On May 16, 2018, nearly 100 people attended the event at the MIND labs at the Charlestown Navy Yard. MIND’s Visiting Day gathering […]
Snapshot of Science: Genetic Insights into Our Food Choices, New Diagnostic Device for Lymphoma and More
What’s new in research at Mass General? Here’s a snapshot of studies recently published in top-tier scientific journals: Effect of folic acid on child brain development Have you ever noticed that everything from cereal to pasta to pancake mix has folic acid listed as an ingredient? This is due to a government-mandated folic acid fortification […]
When it comes to assessing the damage caused by natural disasters, experts often think in terms of primary and secondary effects. A primary effect of a flood, for example, would include the damage to homes and buildings caused by the rushing waters, while a secondary effect would be power outages resulting from downed trees and […]
A new research study from Rudolph Tanzi, PhD, and Robert Moir, PhD, researchers in the Department of Neurology at Massachusetts General Hospital, has uncovered a Jekyll and Hyde role for a naturally occurring protein in the brain most commonly associated with Alzheimer’s disease (AD). In conjunction with new findings from another research team at Icahn School of […]
From the Wall Street Journal to local TedTalks, Massachusetts General Hospital researchers are finding new outlets for sharing their science with the public. Check out just a few recent videos highlighting investigators from Mass General: Twenty Americans die every day waiting for transplants. Now researcher Harald C. Ott, MD, from the Department of Surgery thinks […]